Industry

Syngenta Crop Protection and TraitSeq announce a pioneering collaboration which could help farmers transition to more sustainable practices. BASEL, Switzerland & NORWICH, England–(BUSINESS WIRE)–Syngenta and the pioneering artificial intelligence (AI) company TraitSeq are combining forces to use the full power of AI for the development of innovative, high-performance biostimulants. Syngenta, a world leader in developing … [Read more…]

TOKYO–(BUSINESS WIRE)–Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO:4118) acquired 96.8% of shares of EndoStream Medical Ltd. (Headquarters: Or Akiva, Israel; CEO: Danel Mayer; hereinafter referred to as ESM), an Israeli medical equipment company, on December 23, 2024. By combining Kaneka’s manufacturing and ESM’s technology, we will jointly develop new medical devices, mainly for … [Read more…]

NEW YORK–(BUSINESS WIRE)–Bonerge announced the initiation of its clinical trial, focusing on Fisetin, Urolithin A, and Ergothioneine. Involving 108 participants, this trial aims to evaluate their combined effects on skin health and organ rejuvenation when taking orally, providing more reliable options for the market. Senolytics Research: Advancing the Science of Anti-Aging In recent years, Senolytics … [Read more…]

SAN JOSE, Calif.–(BUSINESS WIRE)–The law firm of Cerri, Boskovich & Allard has filed a sexual abuse lawsuit (Santa Clara County Superior Court) against Trumpet Behavioral Health, LLC and its parent company, BlueSprig, claiming that the businesses were negligent for failing to supervise one of its employees leading to the sexual abuse of a special needs … [Read more…]

New data, published in Nature, advances our understanding of genetic mutations and their role in cancer development ALISO VIEJO, Calif.–(BUSINESS WIRE)–Ambry Genetics, a leader in clinical genomic testing, today announced its contribution to a study published in Nature that significantly advances our understanding of BRCA2 gene variants. As the uptake of genetic testing continues to … [Read more…]

Join Novo Nordisk, Astellas, J&J, Ipsen, Sofinnova Investments, Members of the Media, and 1,200+ Investors New This Year: TechBio Showcase Registration and Partnering Platform Access Now Open SAN FRANCISCO–(BUSINESS WIRE)–#BiotechShowcase–Biotechnology is set for significant transformation in 2025 with an incoming political administration, rapid scientific advancements, and the convergence of technology and biology. Understand how significant … [Read more…]

Groundbreaking LUMOS II ILIM QCL-based IR microscope sets new standards in speed and resolution BILLERICA, Mass.–(BUSINESS WIRE)–$BRKR #BRKR—Bruker Corporation (Nasdaq: BRKR) today announced the launch of the LUMOS™ II ILIM, a quantum cascade laser (QCL) based infrared imaging microscope. The new LUMOS II ILIM redefines performance standards, enabling pharma and life science researchers to capture … [Read more…]

New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. COPENHAGEN, Denmark & PALO ALTO, Calif.–(BUSINESS WIRE)–Glooko, Inc. and Hedia today announced the launch of their interoperable solution, which combines connected care, remote patient monitoring, and digital therapeutic technologies to enhance access for people with Type 1 … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer’s Board of Directors approved the grant, effective January 6, 2025, to … [Read more…]

Full year revenue of ~$84.6 million represents a 15% year-over-year increase Cash balance of ~$185.0 million expected to provide runway to cash flow break-even FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported unaudited preliminary revenue for the fourth quarter and full year ended December 31, 2024 and … [Read more…]